Origin Asset Management’s Emergent Biosolutions EBS Stock Holding History

Origin Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,500	Closed	-$418K	–	138
2021 Q1	$418K	Sell	4,500 -500	-10%	-$51.2K	0.04%	99
2020 Q4	$448K	Sell	5,000 -444	-8%	-$40.8K	0.04%	92
2020 Q3	$563K	Buy	+5,444	New	+$587K	0.06%	79
2016 Q2	–	Sell	-6,936	Closed	-$252K	–	132
2016 Q1	$252K	Hold	6,936	–	–	0.02%	116
2015 Q4	$278K	Buy	+6,936	New	+$242K	0.02%	98

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Origin Asset Management's EBS Position: Q2 2021 in Review

Origin Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 4,500 shares — an estimated $418K sold.

Origin Asset Management first reported a position in EBS in Q4 2015 and held it in 5 quarters. The position peaked at $563K in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Origin Asset Management reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Origin Asset Management sold 4,500 Emergent Biosolutions shares in Q2 2021, an estimated $418K.
Origin Asset Management first reported a position in Emergent Biosolutions in Q4 2015 and held it in 5 quarters.
Origin Asset Management's Emergent Biosolutions position peaked at $563K in Q3 2020.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Origin Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.